Literature DB >> 24830300

Polymersomes as an effective drug delivery system for glioma--a review.

Balakumar Krishnamoorthy1, Vamshikrishna Karanam, Vijaya Raghavan Chellan, Karthik Siram, Tamil Selvan Natarajan, Marslin Gregory.   

Abstract

Glioma is one of the most commonly occurring malignant brain tumours which need proper treatment strategy. The current therapies for treating glioma like surgical resection, radiotherapy, and chemotherapy have failed in achieving satisfactory results and this forms a rationale for the development of novel drug delivery systems. Among them, polymersomes are superior novel carriers with diverse functions like enhanced stability, low permeability, tunable membrane properties, surface functionality, and long blood circulation time which make them suitable for cancer therapy. These are bilayered vesicles capable of encapsulating both hydrophilic and hydrophobic drugs used to target glioma effectively. In this review, we have discussed on general preparation, characterization, and targeting aspects of surface modified polymersomes for effective delivery of therapeutic agents to glioma.

Entities:  

Keywords:  Blood–brain barrier; dual-targeting effect; glioma; polymersomes; receptor-mediated endocytosis; surface functionalization

Mesh:

Substances:

Year:  2014        PMID: 24830300     DOI: 10.3109/1061186X.2014.916712

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  5 in total

Review 1.  Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.

Authors:  Jianing Meng; Vivek Agrahari; Ibrahima Youm
Journal:  J Neuroimmune Pharmacol       Date:  2016-07-23       Impact factor: 4.147

Review 2.  Nanoscale Polymersomes as Anti-Cancer Drug Carriers Applied for Pharmaceutical Delivery.

Authors:  Ruslan G Tuguntaev; Chukwunweike Ikechukwu Okeke; Jing Xu; Chan Li; Paul C Wang; Xing-Jie Liang
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

3.  Stoichioproteomics reveal oxygen usage bias, key proteins and pathways in glioma.

Authors:  Yongqin Yin; Bo Li; Kejie Mou; Muhammad T Khan; Aman C Kaushik; Dongqing Wei; Yu-Juan Zhang
Journal:  BMC Med Genomics       Date:  2019-08-29       Impact factor: 3.063

4.  Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.

Authors:  Fatima Bikhezar; Robin M de Kruijff; Astrid J G M van der Meer; Guzman Torrelo Villa; Susanne M A van der Pol; Gabriel Becerril Aragon; Ana Gasol Garcia; Ravi S Narayan; Helga E de Vries; Ben J Slotman; Antonia G Denkova; Peter Sminia
Journal:  J Neurooncol       Date:  2019-12-24       Impact factor: 4.130

5.  LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo.

Authors:  Chen He; Zhiyuan Zhang; Yinan Ding; Kangli Xue; Xihui Wang; Rui Yang; Yanli An; Dongfang Liu; Chunmei Hu; Qiusha Tang
Journal:  J Nanobiotechnology       Date:  2021-01-22       Impact factor: 10.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.